Vimarsana
Biggest News Aggregation in the World

Bolar Exemption News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bolar Exemption. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bolar Exemption Today - Breaking & Trending Today

The Bolar Exemption And Data Exclusivity: How They Apply In Turkey - Patent - Vimarsana News

The Bolar Exemption And Data Exclusivity: How They Apply In Turkey - Patent

In Turkey, pharmaceutical products for human use cannot be marketed unless they are authorized by the Ministry of Health ("MoH"). In order to grant pharmaceutical license and marketing authorization...

Source: mondaq.com
Africa's First mRNA COVID-19 Vaccine Produced - Vimarsana News

Africa's First mRNA COVID-19 Vaccine Produced

Company hoping for clinical trials in November

Africa's First mRNA COVID-19 Vaccine Produced - New Delhi Times - India Only International Newspaper - Vimarsana News

Africa's First mRNA COVID-19 Vaccine Produced - New Delhi Times - India Only International Newspaper

South African pharmaceutical company Afrigen is the first on the continent to make an mRNA COVID-19 vaccine using Moderna's publicly available data. The company hopes to start clinical trials of the vaccine in November. Afrigen is one of the companies taking part in a World Health Organization-backed hub to develop vaccines for low- and middle-income…

Africa's First mRNA COVID-19 Vaccine Produced - Vimarsana News

Africa's First mRNA COVID-19 Vaccine Produced

Company hoping for clinical trials in November

The European Commission's New Pharmaceutical Strategy For Europe | MoFo Life Sciences - Vimarsana News

The European Commission's New Pharmaceutical Strategy For Europe | MoFo Life Sciences

Nina Schäfer and Jin Ito contributed to this article. On November 25, 2020, the European Commission (the “Commission”) published its “Pharmaceutical Strategy for Europe” which outlines the Commission’s multi-year vision for a more patient-centered pharmaceutical system.  The strategy aims to achieve various goals through legislative and non-legislative actions, namely ensuring access to affordable medicines for patients and addressing unmet medical needs while supporting the competitiveness, innovation and sustainability of the EU’s pharmaceutical sector. It was accompanied by t...